Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
242,696,353
-
Share change
-
+13,286,835
-
Total reported value
-
$9,853,287,513
-
Put/Call ratio
-
65%
-
Price per share
-
$40.60
-
Number of holders
-
736
-
Value change
-
+$527,077,666
-
Number of buys
-
321
-
Number of sells
-
318
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q3 2017
As of 30 Sep 2017,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
736 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
242,696,353 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, DODGE & COX, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, BANK OF AMERICA CORP /DE/, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This page lists
736
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.